Description:

ob represents Obalon Therapeutics Inc., a company listed on the New York Stock Exchange. Obalon Therapeutics is primarily engaged in the development of innovative technologies aimed at addressing obesity through minimally invasive procedures. The company has been at the forefront of creating solutions that help individuals manage their weight without undergoing more invasive surgical options. Its flagship product involves the use of swallowable balloons that assist in reducing caloric intake by creating a feeling of fullness. Obalon's commitment to advancing medical technology for weight management places it as a notable player in the healthcare sector.

Data:

Yields: